We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+8.61%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$14.8B
AUM Growth
+$1.53B
(+12%)
Cap. Flow
+$575M
Cap. Flow
% of AUM
3.88%
Top 10 Holdings %
Top 10 Hldgs %
20.47%
Holding
2,662
New
208
Increased
1,251
Reduced
990
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$56.7M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$43.4M |
| 3 |
Vanguard Extended Market ETF
VXF
|
+$41.1M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$39.4M |
| 5 |
Apple
AAPL
|
+$35.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
C.H. Robinson
CHRW
|
+$26.2M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$25.5M |
| 3 |
Pacer Trendpilot US Large Cap ETF
PTLC
|
+$20.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$18.6M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.79% |
| 2 | Consumer Discretionary | 5% |
| 3 | Healthcare | 4.52% |
| 4 | Financials | 4.2% |
| 5 | Communication Services | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Enbridge
ENB
$112B
| $7.2M | 0.05% |
246,510
+11,782
| +5% | +$371K |
|
|
BSJM
352
DELISTED
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
| $7.19M | 0.05% |
314,380
+155,150
| +97% | +$3.55M |
|
353
iShares International Select Dividend ETF
IDV
$8.51B
| $7.14M | 0.05% |
286,298
+97,784
| +52% | +$2.54M |
|
354
Motley Fool 100 Index ETF
TMFC
$2.11B
| $7.12M | 0.05% |
223,184
+43,478
| +24% | +$1.35M |
|
355
Kraft Heinz
KHC
$29.1B
| $7.11M | 0.05% |
237,215
-37,092
| -14% | -$1.23M |
|
356
Colgate-Palmolive
CL
$73.6B
| $7.08M | 0.05% |
91,796
+6,772
| +8% | +$516K |
|
357
iShares Russell Mid-Cap Value ETF
IWS
$16B
| $7.07M | 0.05% |
87,480
+19,094
| +28% | +$1.55M |
|
358
iShares Russell 3000 ETF
IWV
$20.4B
| $7.06M | 0.05% |
36,086
-1
| -0% | -$193 |
|
359
Amplify Cybersecurity ETF
HACK
$3B
| $7.06M | 0.05% |
151,679
+22,641
| +18% | +$1.07M |
|
360
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
| $7.03M | 0.05% |
74,189
+1,424
| +2% | +$133K |
|
361
CrowdStrike
CRWD
$226B
| $6.92M | 0.05% |
201,536
+89,616
| +80% | +$2.61M |
|
362
KraneShares CSI China Internet ETF
KWEB
$5.45B
| $6.89M | 0.05% |
101,071
+91,052
| +909% | +$6.18M |
|
363
Constellation Brands
STZ
$22.9B
| $6.88M | 0.05% |
36,317
+1,425
| +4% | +$260K |
|
364
Invesco Dorsey Wright Healthcare Momentum ETF
PTH
$245M
| $6.88M | 0.05% |
151,875
+14,253
| +10% | +$628K |
|
365
Invesco S&P 500 Pure Growth ETF
RPG
$2.07B
| $6.86M | 0.05% |
242,315
+97,435
| +67% | +$2.71M |
|
366
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.81B
| $6.86M | 0.05% |
43,615
-9,810
| -18% | -$1.6M |
|
367
Invesco S&P MidCap Momentum ETF
XMMO
$7.63B
| $6.81M | 0.05% |
102,772
+875
| +0.9% | +$56K |
|
368
Becton Dickinson
BDX
$50B
| $6.8M | 0.05% |
29,974
+1,139
| +4% | +$280K |
|
369
iShares US Equity Factor ETF
LRGF
$3.71B
| $6.78M | 0.05% |
204,143
+5,246
| +3% | +$172K |
|
370
Invesco Building & Construction ETF
PKB
$395M
| $6.78M | 0.05% |
+187,041
| New | +$6.4M |
|
371
Norfolk Southern
NSC
$75.3B
| $6.75M | 0.05% |
31,534
+258
| +0.8% | +$51.8K |
|
372
ProShares Large Cap Core Plus
CSM
$533M
| $6.74M | 0.05% |
176,850
-7,550
| -4% | -$285K |
|
373
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.71B
| $6.73M | 0.05% |
108,466
+53,075
| +96% | +$3.16M |
|
374
Twilio
TWLO
$37.9B
| $6.72M | 0.05% |
27,205
+3,697
| +16% | +$911K |
|
375
Schwab US Broad Market ETF
SCHB
$44.9B
| $6.72M | 0.05% |
506,094
-207,384
| -29% | -$2.73M |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q3 2020 Portfolio in Review
As of Q3 2020, Cambridge Investment Research Advisors held 2,662 positions worth $14.8B, up 12% from $13.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $575M of net new capital in Q3 2020, opening 208 new positions and adding to 1,251 existing holdings. Its largest new stake was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was C.H. Robinson, an estimated $26.2M trimmed.
- Cambridge Investment Research Advisors's largest Q3 2020 buy was Invesco Building & Construction ETF: 187,041 shares worth $6.78M.
- Cambridge Investment Research Advisors added most to Bristol-Myers Squibb in Q3 2020, an estimated $56.7M increase.
- Cambridge Investment Research Advisors's biggest Q3 2020 reduction was C.H. Robinson, cutting an estimated $26.2M.
- Cambridge Investment Research Advisors fully exited WisdomTree International ESG Fund in Q3 2020, selling an estimated $11.4M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $14.8B portfolio in Q3 2020.
- Cambridge Investment Research Advisors opened 208 new positions and closed 149 in Q3 2020.
- Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $14.8B.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2020, filed 29 Oct 2020.